A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

(2011) David T. Felson et al.   ARTHRITIS AND RHEUMATISM

28-joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project

(2011) E. Hallert et al.   RHEUMATOLOGY

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis

(2009) Y P M Goekoop-Ruiterman et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis

(2009) Aline Ranzolin et al.   ARTHRITIS AND RHEUMATISM

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

(2008) Josef S Smolen et al.   ARTHRITIS RESEARCH & THERAPY

Efficient management of rheumatoid arthritis significantly reduces long-term functional disability

(2007) E Tanaka et al.   ANNALS OF THE RHEUMATIC DISEASES